MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
17.22
-1.42 (-7.62%)
Apr 1, 2026, 11:50 AM EDT - Market open
MLTX Market Cap
MLTX has a market cap or net worth of $1.24 billion as of April 1, 2026. Its market cap has decreased by -49.53% in one year.
Market Cap
1.24B
Enterprise Value
1.02B
1-Year Change
-49.53%
Ranking
Category
Stock Price
$17.22
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.24B, an increase of 34,228.15%. That is a compound annual growth rate of 311.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 1.34B | 42.13% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savara | 1.30B |
| Precigen | 1.30B |
| Biohaven | 1.26B |
| Immatics | 1.26B |
| Monte Rosa Therapeutics | 1.23B |
| AtaiBeckley | 1.22B |
| ORIC Pharmaceuticals | 1.21B |
| Wave Life Sciences | 1.20B |